AHIP to Congress: COVID-19 test price gouging still a problem

COVID-19 test price gouging is still a “significant problem,” America’s Health Insurance Plans said in a statement submitted to Congress.

Advertisement

The statement was submitted Feb. 2 for a House Committee on Energy and Commerce Subcommittee on Consumer Protection and Commerce hearing targeting pandemic-era price gouging. 

According to an AHIP survey of payers, more than half of out-of-network COVID-19 test providers charged over $185 per test, according to a news release. The average price was $130, and data continues to show price gouging has gotten worse as the pandemic progresses. 

To battle price gouging, AHIP proposed legislation that allows payers to bill out-of-network COVID-19 test providers the median in-network rate for testing. The group also encouraged CDC and CMS to update ICD-10 and HCPCS billing codes for COVID-19 tests. 

“Health insurance providers are committed to working with Congress to pass legislation that eliminates price gouging and sets a reasonable market-based pricing benchmark for out-of-network COVID-19 tests, allows for appropriate tracking of tests administered and makes OTC tests universally available,” AHIP said.

At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.

Advertisement

Next Up in Policy Updates

Advertisement

Comments are closed.